Written answers

Wednesday, 15 January 2014

Department of Health

Medicinal Products Availability

Photo of Michael McGrathMichael McGrath (Cork South Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

894. To ask the Minister for Health the position regarding the drug anafranil which is prescribed to patients with severe depression; and if he will confirm its continued availability here for patients that are taking it long term. [1605/14]

Photo of Alex WhiteAlex White (Dublin South, Labour)
Link to this: Individually | In context | Oireachtas source

My Department is aware of a disruption in supply of Anafranil 10mg, 25mg and 50mg capsules (immediate release) on the Irish and UK market. The disruption relates to manufacturing issues which the marketing authorisation holder Novartis is working to resolve. Supply of Anafranil SR 75mg prolonged-release tablets remain unaffected.

The supply issue should not affect patients who are on maintenance treatment with Anafranil SR 75mg tablets which is used where a patient has been stable on Anafranil for some time.

Comments

No comments

Log in or join to post a public comment.